TONBUL, H. Et Al. 2024. An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles. Journal of Drug Targeting , vol.32, no.9 , 1101-1110.

TONBUL, H., ŞAHİN, A., ÖZTÜRK, S. C., ULTAV, G., Tavukçuoğlu, E., Akbaş, S., ... AKTAŞ, Y.(2024). An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles. Journal of Drug Targeting , vol.32, no.9, 1101-1110.

TONBUL, HAYRETTİN Et Al. "An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles," Journal of Drug Targeting , vol.32, no.9, 1101-1110, 2024

TONBUL, HAYRETTİN Et Al. "An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles." Journal of Drug Targeting , vol.32, no.9, pp.1101-1110, 2024

TONBUL, H. Et Al. (2024) . "An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles." Journal of Drug Targeting , vol.32, no.9, pp.1101-1110.

@article{article, author={HAYRETTİN TONBUL Et Al. }, title={An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles}, journal={Journal of Drug Targeting}, year=2024, pages={1101-1110} }